Isolation in the allogeneic transplant environment: how protective is it?
- 13 June 2005
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (5) , 373-381
- https://doi.org/10.1038/sj.bmt.1705040
Abstract
Aggressive infection control measures that include isolating patients within protective hospital environments have become a standard practice during allogeneic stem cell transplantation. A wide range of interventions includes the management of ventilation systems, BMT unit construction and cleaning, isolation and barrier precautions, interactions with health-care workers and visitors, skin and oral care, infection surveillance, and the prevention of specific nosocomial and seasonal infections. However, many of these practices have not been definitively proven to provide patients the intended benefit of decreased infection rates or improved survival. Furthermore, each intervention comes with a financial and social cost. With institutional cost containment efforts and recent trials suggesting that patients may be safely cared for in the outpatient environment after allogeneic transplantation, many widely held practices in managing the transplant environment are being reconsidered. With changing practices, transplant teams are encouraged to review local patterns of infections and associated complications and communicate regularly with infection control committees for guidance on the evolution of isolation needs for the immunosuppressed patient.Keywords
This publication has 56 references indexed in Scilit:
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- Monoclonal antibody IAC-1 is specific for activated α2β1 and binds to amino acids 199 to 201 of the integrin α2 I-domainBlood, 2004
- Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital careBlood, 2002
- Isolation in Blood and Marrow TransplantationWestern Journal of Nursing Research, 2001
- Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic FluconazoleThe Journal of Infectious Diseases, 2000
- An Outbreak of Vancomycin-Dependent Enterococcus faecium in a Bone Marrow Transplant UnitClinical Infectious Diseases, 1999
- Recommendations for Preventing the Spread of Vancomycin ResistanceEmerging Infectious Diseases, 1995
- An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant CenterThe Journal of Infectious Diseases, 1992
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983
- Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemiaThe Lancet Healthy Longevity, 1971